BACKGROUND: Changes in oncology care and the diagnosis and management of influenza over the past several decades may have altered the epidemiology and outcomes of influenza in pediatric oncology patients. METHODS: The clinical features and outcomes of 102 pediatric patients undergoing cancer therapy during 107 episodes of influenza between January 2002 and April 2009 were retrospectively ascertained. RESULTS: Median age at the time of influenza was 7.2 years (interquartile range: 3.8-11.2 years); 46% of patients were male. Nineteen patients (18%) were recipients of hematopoietic stem cell transplants. Patients' median absolute neutrophil and lymphocyte counts were 1300/μL (interquartile range: 500-2967/μL) and 360/μL (interquartile range: 180-836/μL), respectively. Twelve patients (11%) had coinfections with influenza and one or more other respiratory pathogens. Influenza prompted patients' hospitalization during 64% of episodes, and 75% received antiviral therapy. Complications occurred in 30% of infections and serious complications occurred in 7%. Three patients died, but no deaths were directly attributable to influenza. Most patients had delays in cancer therapy; the median delay was 5 days. Neutropenia, concurrent infection, increasing age and having received hematopoietic stem cell transplant increased the risk of serious complications. CONCLUSIONS: Advances in the management of pediatric cancer and influenza have not altered the epidemiology and outcome of influenza in oncology patients. Clinical features identify subgroups of patients with influenza who are at risk of poor outcomes and those with a good prognosis.
BACKGROUND: Changes in oncology care and the diagnosis and management of influenza over the past several decades may have altered the epidemiology and outcomes of influenza in pediatric oncology patients. METHODS: The clinical features and outcomes of 102 pediatric patients undergoing cancer therapy during 107 episodes of influenza between January 2002 and April 2009 were retrospectively ascertained. RESULTS: Median age at the time of influenza was 7.2 years (interquartile range: 3.8-11.2 years); 46% of patients were male. Nineteen patients (18%) were recipients of hematopoietic stem cell transplants. Patients' median absolute neutrophil and lymphocyte counts were 1300/μL (interquartile range: 500-2967/μL) and 360/μL (interquartile range: 180-836/μL), respectively. Twelve patients (11%) had coinfections with influenza and one or more other respiratory pathogens. Influenza prompted patients' hospitalization during 64% of episodes, and 75% received antiviral therapy. Complications occurred in 30% of infections and serious complications occurred in 7%. Three patients died, but no deaths were directly attributable to influenza. Most patients had delays in cancer therapy; the median delay was 5 days. Neutropenia, concurrent infection, increasing age and having received hematopoietic stem cell transplant increased the risk of serious complications. CONCLUSIONS: Advances in the management of pediatric cancer and influenza have not altered the epidemiology and outcome of influenza in oncology patients. Clinical features identify subgroups of patients with influenza who are at risk of poor outcomes and those with a good prognosis.
Authors: Jonathan A McCullers; Kathleen M Speck; Bonnie F Williams; Hua Liang; Joseph Mirro Journal: Infect Control Hosp Epidemiol Date: 2006-01-06 Impact factor: 3.254
Authors: A Kempe; C B Hall; N E MacDonald; H R Foye; K A Woodin; H J Cohen; E D Lewis; M Gullace; C L Gala; C S Dulberg; E Katsanis Journal: J Pediatr Date: 1989-07 Impact factor: 4.406
Authors: María Carmen Mendoza Sánchez; Jesús Ruiz-Contreras; José L Vivanco; Francisco Fernández-Carrión; María Baro Fernández; José T Ramos; Joaquin R Otero; Dolores Folgueira Journal: J Pediatr Hematol Oncol Date: 2006-03 Impact factor: 1.289
Authors: Minna Koskenvuo; Merja Möttönen; Jaana Rahiala; Ulla M Saarinen-Pihkala; Pekka Riikonen; Matti Waris; Thedi Ziegler; Matti Uhari; Toivo T Salmi; Olli Ruuskanen Journal: Pediatr Infect Dis J Date: 2008-11 Impact factor: 2.129
Authors: Roy F Chemaly; Harrys A Torres; Elizabeth A Aguilera; Gloria Mattiuzzi; Maria Cabanillas; Hagop Kantarjian; Virginia Gonzalez; Amar Safdar; Issam I Raad Journal: Clin Infect Dis Date: 2007-02-14 Impact factor: 9.079
Authors: Matthew W Smith; Jeffrey E Schmidt; Jerold E Rehg; Carlos J Orihuela; Jonathan A McCullers Journal: Comp Med Date: 2007-02 Impact factor: 0.982
Authors: Aleksandra Pettke; Sophie Jocham; Andreas Wiener; Andreas Löcken; Judith Groenefeld; Martina Ahlmann; Andreas H Groll Journal: Support Care Cancer Date: 2017-07-21 Impact factor: 3.603
Authors: Grace E Lee; Brian T Fisher; Rui Xiao; Susan E Coffin; Kristen Feemster; Alix E Seif; Rochelle Bagatell; Yimei Li; Yuan-Shung V Huang; Richard Aplenc Journal: J Pediatric Infect Dis Soc Date: 2014-07-22 Impact factor: 3.164
Authors: Rishi S Kotecha; Ushma D Wadia; Peter Jacoby; Anne L Ryan; Christopher C Blyth; Anthony D Keil; Nicholas G Gottardo; Catherine H Cole; Ian G Barr; Peter C Richmond Journal: Cancer Med Date: 2015-12-29 Impact factor: 4.452